Brought to you by 
Zealand teams with Protagonist for peptide drug discovery/development
11 Oct 2012
Executive Summary
Danish biotech Zealand Pharma AS (cardiovascular, metabolic, and gastrointestinal disorders) will collaborate with fellow peptide drug developer Protagonist Therapeutics Inc. on the discovery and development of novel disulfide-rich peptide (DRP) candidates across various therapeutic areas that Zealand Pharma has already identified.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Zealand teams with Protagonist for peptide drug discovery/development
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice